Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 USD | +4.73% | +5.80% | +29.17% |
05-17 | Capital One Initiates Immutep at Overweight Rating With $10 Price Target | MT |
05-15 | Immutep Says Safety Lead-in Phase of Breast Cancer Study Yields 'Encouraging' Data | MT |
Evolution of the average Target Price on Immutep ADR
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Immutep ADR
Capital One Securities | |
Canaccord Genuity | |
Baird | |
Maxim | |
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- IMM Stock
- IMMP Stock
- Consensus Immutep ADR